Portage Biotech Inc. - Common Stock (PRTG)

Portage Biotech Inc is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of cancer

The company is dedicated to advancing its proprietary drug candidates through various stages of clinical development, aiming to address unmet medical needs in oncology. By leveraging its scientific expertise and strategic partnerships, Portage is engaged in researching and developing novel immunotherapies and personalized medicine approaches that aim to improve patient outcomes and enhance the efficacy of existing cancer treatments.